LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
The AstraZeneca share price: 3 things UK investors should know now

Investing Articles
AstraZeneca shares: should I buy now?

Investing Articles
Why is the AstraZeneca share price down nearly 8% this week?

Investing Articles
AstraZeneca shares: is the company a bargain after the vaccine candidate news?
Investing Articles
At 8,000p, is FTSE 100 company AstraZeneca a share worth me buying right now?
Investing Articles
AstraZeneca share price: Here’s my verdict after the Covid-19 vaccine news
Investing Articles
Covid-19 vaccine: 1 biotech stock that profits from AstraZeneca’s success
Investing Articles
AstraZeneca share price: 4 reasons I’d buy after its Covid-19 vaccine results
